Andres Gutierrez, Ph.D.

EpiVax, Inc.

Poster(s):

• (T1530-06-32) Immunogenicity Risk Assessment for Host Cell Proteins in Vaccines and Biologics
  Tuesday, October 18, 2022

  3:30 PM – 4:30 PM ET

• (M1330-02-09) More than the Sum of Its Parts: In Silico Immunogenicity Risk Assessment for Fusion Proteins and Novel Antibody Modalities
  Monday, October 17, 2022

  1:30 PM – 2:30 PM ET